Infectious Disease Control
CanSinoBIO's Convidecia™ Approved as Heterologous Booster in China
TIANJIN, China, Feb. 21, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO") (SSE: 688185, HKEX: 06185) announced that its Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) ("Ad5-nCoV", trade name: Convidecia™) has been approved by the Joint Prevention and Control Mechanism ...
2022-02-21 08:05
2832
BioWorld by Clarivate Provides In-depth Analyses of Long COVID Studies, Potentially the Next Public Health Crisis
40-plus therapeutics in development even as researchers are trying to reach consensus on the syndrome LONDON, Feb. 17, 2022 /PRNewswire/ -- BioWorld published by Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, has ann...
2022-02-17 16:00
2735
NIBIOHN, Shionogi Discover Host Immune-dependent Novel Anti-coronavirus Antibody
OSAKA, Japan, Feb. 16, 2022 /PRNewswire/ -- The National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN;Ibaraki-shi, Osaka; Director-general:Yoshihiro Yoneda), in partnership with Shionogi & Co., Ltd. (Chuo-ku,Osaka; President and CEO: Isao Teshirogi), has successfully identif...
2022-02-16 14:00
1959
HPG: New Breakthrough in Virus Inactivation with Green Tea Catechin (EGCg)
TOKYO, Feb. 15, 2022 /PRNewswire/ -- HPG Co., Ltd. (Chuo-ku, Tokyo) has successfully developed a water-soluble formulation technology of highly concentrated catechin EGCg (Epigallocatechin gallate) with excellent storage stability and initiated procedures for a patent application for the technolo...
2022-02-15 16:00
1288
Singapore Health Sciences Authority Issues Interim Authorization for Novavax COVID-19 Vaccine
Nuvaxovid™ is the first protein-based COVID-19 vaccine authorized for use in Singapore GAITHERSBURG, Md., Feb. 15, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, toda...
2022-02-15 05:02
2092
Shanghai Public Health Clinical Center Initiated Functional Cure Study of Anti-PD-L1 Antibody ASC22 (Envafolimab) in Combination With Chidamide in HIV-Infected Patients
HANGZHOU, China and SHAOXING, China, Feb. 14, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) today announces that Shanghai Public Health Clinical Center initiated functional cure study of anti-PD-L1 antibody ASC22 (Envafolimab) in combination with Chidamide in patients infected by human ...
2022-02-14 17:34
2878
Novavax Announces Positive Results of COVID-19 Vaccine in Pediatric Population of PREVENT-19 Phase 3 Clinical Trial
- PREVENT-19 pediatric expansion in adolescents aged 12 through 17 achieved primary effectiveness endpoint demonstrating comparability to adult population - Trial demonstrated 82% clinical efficacy against Delta variant - Immune responses were about two-to-three-fold higher in adolescents than in...
2022-02-11 10:45
3089
Seegene Signs Supply Deal to Deliver 4 million COVID-19 Tests to Brazil
SEOUL, South Korea, Feb. 10, 2022 /PRNewswire/ -- Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostic company, today announced that it has signed a supply deal with the Ministry of Health ofBrazil to deliver four million COVID-19 tests. Since January 2022, Brazil has battled a...
2022-02-10 20:00
2185
Bactiguard presents focused growth strategy and sets new long-term financial targets
STOCKHOLM, Feb. 9, 2022 /PRNewswire/ -- Bactiguard presents new long-term financial targets in connection with the year-end report for 2021. The new financial targets relate to growth and profitability, with annual revenues of at least1 billion SEK and annual EBITDA of at least 400 million SEK in...
2022-02-09 07:27
1809
mRNA COVID-19 Vaccines are Safe for People with Cancer According to New Study in JNCCN
Researchers at Fox Chase Cancer Center conducted the largest published, peer-reviewed, study to-date examining the short-term adverse effects of mRNA COVID-19 vaccination in patients with cancer—finding they experienced no more, and no different, side effects compared to non-cancer patients. PLY...
2022-02-08 05:11
2011
'2022 Sunhak Peace Prize Focuses on Vaccine Equity'
SEOUL, South Korea, Feb. 7, 2022 /PRNewswire/ -- On February 7, 2022, the Sunhak Peace Prize Committee (ChairmanJose Manuel Barroso, former President of the European Commission) will announce the 2022 Sunhak Peace Prize laureates are DameSarah Catherine Gilbert (age 59), Professor of Vaccinology ...
2022-02-07 18:00
2547
The one-component Sputnik Light vaccine has been authorized in India; over 2.5 billion people live in countries that approved Sputnik Light as a standalone vaccine and a universal booster
Sputnik Light will be an important part of India's vaccination program and the fight against mutations of COVID, including Omicron. Sputnik Light has been authorized in more than 30 countries with total population of over 2.5 billion people. MOSCOW, Feb. 7, 2022 /PRNewswire/ -- The Russian Dir...
2022-02-07 08:18
2679
New Zealand's Medsafe Grants Provisional Approval for Novavax' COVID-19 Vaccine
Nuvaxovid™ is the first protein-based COVID-19 vaccine to receive provisional approval for distribution inNew Zealand GAITHERSBURG, Md., Feb. 4, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for ser...
2022-02-04 06:54
2319
Medicines and Healthcare Products Regulatory Agency Grants Conditional Marketing Authorization for Novavax COVID-19 Vaccine in Great Britain*
* Nuvaxovid™ COVID-19 Vaccine (recombinant, adjuvanted)▼ is the first protein-based COVID-19 vaccine authorized inGreat Britain * Novavax and the U.K. Vaccines Taskforce previously announced an agreement for up to 60 million doses * Authorization based on data including an ongoing pivotal Ph...
2022-02-03 21:22
3011
Novavax Submits Request to the U.S. FDA for Emergency Use Authorization of COVID-19 Vaccine
- NVX-CoV2373 demonstrated overall efficacy of ~90% in PREVENT-19 clinical trial conducted during the emergence of variant strains GAITHERSBURG, Md., Feb. 1, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vac...
2022-02-01 04:06
3019
100 LANDMARKS ACROSS THE WORLD LIGHT UP IN UNITY TO RAISE AWARENESS TO END NEGLECTED TROPICAL DISEASES ON WORLD NTD DAY 2022
ABU DHABI, UAE, Feb. 1, 2022 /PRNewswire/ -- 100 landmarks in 32 countries lit up in unity to mark the third annual World NTD Day onJanuary 30, 2022 including The Bell Tower inPerth, Tokyo Tower, Great Wall of China, New Delhi Railway Station, SheikhZayed Bridge in Abu Dhabi, Expo 2020 Dubai, Ken...
2022-02-01 03:31
1560
Sqkii's S$100,000 #HuntTheMouse is Back -- First Ever Safe Distancing Hybrid Hunt
SINGAPORE, Jan. 31, 2022 /PRNewswire/ -- Singapore's viral #HuntTheMouse cash
hunt bySqkii
2022-01-31 16:49
2849
"Don't forget leprosy" campaign gathers pace as World Leprosy Day approaches
TOKYO, Jan. 28, 2022 /PRNewswire/ -- Sasakawa Leprosy (Hansen's Disease) Initiative is collaborating with 32 organizations from 13 countries to promote the message "Don't forget leprosy" in the run-up to World Leprosy Day onJanuary 30. The international campaign includes awareness-raising events ...
2022-01-28 19:00
1617
Ready to Enter the Middle East Market, Vazyme Showcases Its COVID-19 Testing Solutions at Medlab Middle East 2022
DUBAI, UAE, Jan. 28, 2022 /PRNewswire/ -- Leading China-based biotech company Vazyme (688105.SH) participated in the 2022 edition of Medlab Middle East in the Dubai World Trade Centre (DWTC) fromJanuary 24th to 27th, a leading laboratory and flagship exhibition and conference that brings together...
2022-01-28 13:00
3442
Brii Bio Appoints Karen D. Neuendorff as Chief People Officer and Head of Human Resources
DURHAM, N.C. and BEIJING, Jan. 27, 2022 /PRNewswire/ -- Brii Biosciences
2022-01-27 21:00
2955
Week's Top Stories
Most Reposted
Multiple achievements made in China-Hungary BRI conference
[Picked up by 319 media titles]
2024-05-03 06:59
Shanghai Jiao Tong University Offers Free Online Courses for International Learners, Joint Programs with Tmall of Alibaba and Dow Gain High Popularity
[Picked up by 314 media titles]
2024-05-07 08:00
Xinhua president, Hungarian economy minister vow to bolster media cooperation
[Picked up by 289 media titles]
2024-05-03 06:25TAILG Makes Grand Appearance at 2024 Asiabike Jakarta, Aiming to Set the Benchmark in Indonesia
[Picked up by 262 media titles]
2024-05-02 01:21
China-Serbia forum highlights community with shared future for mankind
[Picked up by 245 media titles]
2024-05-01 11:39
Most Read
/C O R R E C T I O N -- Addverb/
2024-05-03 20:26
12716
Multiple achievements made in China-Hungary BRI conference
2024-05-03 06:59
8214
Xinhua president, Hungarian economy minister vow to bolster media cooperation
2024-05-03 06:25
7746
